Back
Monte Rosa Therapeutics 10K Form
Sell
11
GLUE
Monte Rosa Therapeutics
Last Price:
$7.07
Seasonality Move:
-3.94%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GLUE News And Ratings
See the #1 stock for the next 7 days that we like better than GLUE
GLUE Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-21.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.35 |
| Price / Book: | 2.11 |
Profitability
| EPS (TTM): | -1.83000 |
|---|---|
| Net Income (TTM): | $-119.4M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Monte Rosa Therapeutics Earnings Forecast
Key Monte Rosa Therapeutics Financial Ratios
-
The Interest Expense is -0.01% of Operating Income.
-
Per Share Earnings over the last 5 years have been positive in 1 years.
Monte Rosa Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | GLUE |
| Website: | monterosatx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 6.03 |
| Quick Ratio: | 5.83 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
GLUE Technical Analysis vs Fundamental Analysis
Sell
11
Monte Rosa Therapeutics (GLUE)
is a Sell
Is Monte Rosa Therapeutics a Buy or a Sell?
-
Monte Rosa Therapeutics stock is rated a SellThe current Monte Rosa Therapeutics [GLUE] share price is $7.05. The Score for GLUE is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.